載入...
Phase I study of oral S-1 and concurrent radiotherapy in patients with head and neck cancer
This study investigated the maximum tolerated dose (MTD) of S-1 with concurrent radiotherapy in patients with head and neck cancer, based on the frequency of dose-limiting toxicities (DLT). S-1 was administered orally at escalating doses from 40 mg/m(2) b.i.d. on the days of delivering radiotherapy,...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3709662/ https://ncbi.nlm.nih.gov/pubmed/23292146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jrr/rrs133 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|